Kristin P O'Grady1, Adrienne N Dula2, Bailey D Lyttle1, Lindsey M Thompson1, Benjamin N Conrad3, Bailey A Box1, Lydia J McKeithan1, Siddharama Pawate4, Francesca Bagnato5, Bennett A Landman6, Paul Newhouse7, Seth A Smith8. 1. Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA. 3. Neuroscience Graduate Program, Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Vanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Neuroimaging Unit, Neuroimmunology Division, Vanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. 6. Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. 7. Department of Psychiatry and Behavioral Sciences, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, TN, USA/Veterans Affairs Tennessee Valley Healthcare System Geriatric Research, Education, and Clinical Center (VA TVHS GRECC), Nashville, TN, USA. 8. Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
BACKGROUND: Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T1- and T2-weighted magnetic resonance imaging (MRI). There is a need for high-resolution, clinically accessible imaging techniques that probe molecular changes in GM. OBJECTIVE: To study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0 Tesla (7T). METHODS: A total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI. RESULTS AND CONCLUSION: Glutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability (p < 0.05). In addition, glutamate-sensitive contrast in the prefrontal cortex was significantly correlated with symbol digit modality test (rS = -0.814) and choice reaction time (rS = 0.772) scores in patients (p < 0.05), suggesting that GluCEST MRI may have utility as a marker for GM pathology and CI.
BACKGROUND:Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T1- and T2-weighted magnetic resonance imaging (MRI). There is a need for high-resolution, clinically accessible imaging techniques that probe molecular changes in GM. OBJECTIVE: To study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0 Tesla (7T). METHODS: A total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI. RESULTS AND CONCLUSION:Glutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability (p < 0.05). In addition, glutamate-sensitive contrast in the prefrontal cortex was significantly correlated with symbol digit modality test (rS = -0.814) and choice reaction time (rS = 0.772) scores in patients (p < 0.05), suggesting that GluCEST MRI may have utility as a marker for GM pathology and CI.
Authors: Kathryn Adamiak Davis; Ravi Prakash Reddy Nanga; Sandhitsu Das; Stephanie H Chen; Peter N Hadar; John R Pollard; Timothy H Lucas; Russell T Shinohara; Brian Litt; Hari Hariharan; Mark A Elliott; John A Detre; Ravinder Reddy Journal: Sci Transl Med Date: 2015-10-14 Impact factor: 17.956
Authors: Jeroen J G Geurts; Ilona E W Reuling; Hugo Vrenken; Bernard M J Uitdehaag; Chris H Polman; Jonas A Castelijns; Frederik Barkhof; Petra J W Pouwels Journal: Magn Reson Med Date: 2006-03 Impact factor: 4.668
Authors: Kejia Cai; Mohammad Haris; Anup Singh; Feliks Kogan; Joel H Greenberg; Hari Hariharan; John A Detre; Ravinder Reddy Journal: Nat Med Date: 2012-01-22 Impact factor: 53.440
Authors: A M Thomas; S Li; C Chu; I Shats; J Xu; P A Calabresi; P C M van Zijl; P Walczak; J W M Bulte Journal: Exp Neurol Date: 2020-04-15 Impact factor: 5.330
Authors: Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson Journal: Curr Opin Chem Biol Date: 2021-07-20 Impact factor: 8.972
Authors: Alex K Smith; Kevin J Ray; James R Larkin; Martin Craig; Seth A Smith; Michael A Chappell Journal: Magn Reson Med Date: 2020-02-18 Impact factor: 4.668
Authors: Kristen R Hollinger; Matthew D Smith; Leslie A Kirby; Eva Prchalova; Jesse Alt; Rana Rais; Peter A Calabresi; Barbara S Slusher Journal: Neurol Neuroimmunol Neuroinflamm Date: 2019-08-29
Authors: Kristin P O'Grady; Sanjana Satish; Quinn R Owen; Bailey A Box; Francesca Bagnato; Anna J E Combes; Sarah R Cook; Holly James Westervelt; Haley R Feiler; Richard D Lawless; Asha Sarma; Shekinah D Malone; Josephine M Ndolo; Keejin Yoon; Richard D Dortch; Baxter P Rogers; Seth A Smith Journal: Front Neurol Date: 2022-02-25 Impact factor: 4.003